NO148150C - Analogifremstilling av terapeutisk aktive piperazinderivater - Google Patents

Analogifremstilling av terapeutisk aktive piperazinderivater

Info

Publication number
NO148150C
NO148150C NO774307A NO774307A NO148150C NO 148150 C NO148150 C NO 148150C NO 774307 A NO774307 A NO 774307A NO 774307 A NO774307 A NO 774307A NO 148150 C NO148150 C NO 148150C
Authority
NO
Norway
Prior art keywords
analogy
preparation
piperazine derivatives
therapeutic active
active piperazine
Prior art date
Application number
NO774307A
Other languages
English (en)
Norwegian (no)
Other versions
NO774307L (no
NO148150B (no
Inventor
Johan Gootjes
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of NO774307L publication Critical patent/NO774307L/no
Publication of NO148150B publication Critical patent/NO148150B/no
Publication of NO148150C publication Critical patent/NO148150C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO774307A 1976-12-14 1977-12-14 Analogifremstilling av terapeutisk aktive piperazinderivater NO148150C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB52223/76A GB1545094A (en) 1976-12-14 1976-12-14 Piperazine derivatives

Publications (3)

Publication Number Publication Date
NO774307L NO774307L (no) 1978-06-15
NO148150B NO148150B (no) 1983-05-09
NO148150C true NO148150C (no) 1983-08-24

Family

ID=10463103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO774307A NO148150C (no) 1976-12-14 1977-12-14 Analogifremstilling av terapeutisk aktive piperazinderivater

Country Status (22)

Country Link
US (2) US4202896A (pt)
JP (1) JPS5382789A (pt)
AT (1) AT363090B (pt)
AU (1) AU516920B2 (pt)
BE (1) BE861853A (pt)
DE (1) DE2755752A1 (pt)
DK (1) DK147421C (pt)
ES (6) ES465047A1 (pt)
FI (1) FI69839C (pt)
GB (1) GB1545094A (pt)
HU (1) HU177999B (pt)
IE (1) IE46278B1 (pt)
IL (1) IL53597A0 (pt)
IT (1) IT1093045B (pt)
LU (1) LU78686A1 (pt)
NL (1) NL7713817A (pt)
NO (1) NO148150C (pt)
NZ (1) NZ185981A (pt)
PT (1) PT67400B (pt)
SE (1) SE435378B (pt)
YU (1) YU295877A (pt)
ZA (1) ZA777452B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0042366B1 (en) * 1980-06-16 1984-11-07 AB Ferrosan Diphenylbutyl-1-acylpiperazines
NL8202636A (nl) * 1982-06-29 1984-01-16 Gist Brocades Nv Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5162537A (en) * 1986-04-17 1992-11-10 Monsanto Company Benzhydryl compounds as herbicide antidotes
HU196194B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
HU196196B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds
HU196195B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
FR2636946B1 (fr) * 1988-09-23 1990-11-02 Lipha ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
US5087627A (en) * 1989-03-15 1992-02-11 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
US5153198A (en) * 1989-03-15 1992-10-06 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
DK178490D0 (da) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
DE69426771T2 (de) * 1993-06-25 2001-06-13 Pola Chemical Industries, Inc. Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms
DE60135634D1 (de) * 2000-01-11 2008-10-16 Molecular Insight Pharm Inc Polypharmacophore verbindungen
US6743797B2 (en) 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US20050054010A1 (en) * 2003-07-15 2005-03-10 Brown Arthur M. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050208595A1 (en) * 2004-03-19 2005-09-22 Brown Arthur M High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
FR2884712B1 (fr) * 2005-04-21 2007-06-15 Oreal Compositions cosmetiques comprenant des derives de piperazine
CA2614116A1 (en) * 2005-07-04 2007-01-11 Novo Nordisk A/S Novel medicaments
US8318927B2 (en) * 2006-05-23 2012-11-27 High Point Pharmaceuticals, Llc 6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament
CN102295606A (zh) * 2006-05-29 2011-12-28 高点制药有限责任公司 合成3-（1，3-苯并间二氧杂环戊烯-5-基）-6-（4-环丙基哌嗪-1-基）-哒嗪的方法及其适用的中间体
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US20120028992A1 (en) * 2010-08-02 2012-02-02 Brown Arthur M Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
CN104529942B (zh) * 2014-12-10 2018-05-15 天津孚音生物科技发展有限公司 一种伐诺司林的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837986A (en) 1956-07-10 1960-06-22 Henri Morren New piperazine derivatives and process for the preparation thereof
US2953568A (en) * 1958-03-03 1960-09-20 Ciba Pharm Prod Inc Derivatives of piperazine
CH410961A (de) * 1961-02-22 1966-04-15 Yoshitomi Pharmaceutical Verfahren zur Herstellung N-substituierter Piperazinderivate
DE1445692A1 (de) 1963-03-25 1969-03-20 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von Piperazinderivaten
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
JPS504086A (pt) * 1973-01-18 1975-01-16

Also Published As

Publication number Publication date
FI69839C (fi) 1986-05-26
NZ185981A (en) 1980-02-21
ES473816A1 (es) 1979-04-16
DK147421B (da) 1984-07-30
PT67400B (en) 1979-05-21
GB1545094A (en) 1979-05-02
ES473814A1 (es) 1979-04-16
NO774307L (no) 1978-06-15
FI69839B (fi) 1985-12-31
LU78686A1 (pt) 1978-04-17
SE7714184L (sv) 1978-06-15
ES473815A1 (es) 1979-05-01
NL7713817A (nl) 1978-06-16
ES473818A1 (es) 1979-04-16
US4202896A (en) 1980-05-13
DE2755752C2 (pt) 1991-12-05
NO148150B (no) 1983-05-09
IT1093045B (it) 1985-07-19
FI773786A (fi) 1978-06-15
IE46278B1 (en) 1983-04-20
BE861853A (fr) 1978-06-14
IL53597A0 (en) 1978-03-10
YU295877A (en) 1983-01-21
DK557277A (da) 1978-06-15
AU3157377A (en) 1979-06-21
HU177999B (en) 1982-02-27
JPS5382789A (en) 1978-07-21
JPS6215546B2 (pt) 1987-04-08
IE46278L (en) 1978-06-14
AT363090B (de) 1981-07-10
ES473817A1 (es) 1979-04-16
ES465047A1 (es) 1979-01-01
US4265894A (en) 1981-05-05
AU516920B2 (en) 1981-07-02
DK147421C (da) 1985-02-11
PT67400A (en) 1978-01-01
DE2755752A1 (de) 1978-06-15
ATA891177A (de) 1980-12-15
ZA777452B (en) 1978-10-25
SE435378B (sv) 1984-09-24

Similar Documents

Publication Publication Date Title
NO148150C (no) Analogifremstilling av terapeutisk aktive piperazinderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO146774C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazin- og piperidinderivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NO150044C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO145951C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater
NO148524C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater av guanidin
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO146710C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylpiperazinderivater
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO146600C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater
NO145656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater